Malignancies in patients on dialysis;Dialyzační léčení a maligní onemocnění

Casopis Lekaru Ceskych

Volumn 144, Issue 5, 2005, Pages 298-302

  Motáň, Jiří ^a,b   Krizek M ^a   Finek J ^a   Mukensnabl P ^a   Petruželka, Luboš ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b FN ^*  (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Dialysis; Malignancies; Renal failure

Indexed keywords

ETHYLENE OXIDE; NITROSAMINE; PARAPROTEIN; PHTHALIC ACID; TUMOR MARKER;

ANALGESIC NEPHROPATHY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER RISK; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHINESE HERB; HEMODIALYSIS PATIENT; HUMAN; IMMUNE DEFICIENCY; INFECTION; INTERSTITIAL NEPHRITIS; KIDNEY CYST; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY TUMOR; LUNG EDEMA; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE MYELOMA; NEPHRECTOMY; NEPHROBLASTOMA; PERITONEAL DIALYSIS; RADIATION INJURY; REVIEW; SELENIUM DEFICIENCY; TUMOR LYSIS SYNDROME; URINARY TRACT TUMOR; VON HIPPEL LINDAU DISEASE; NEOPLASM; RENAL REPLACEMENT THERAPY; RISK FACTOR;

HUMANS; NEOPLASMS; RENAL DIALYSIS; RISK FACTORS;

EID: 20344396655     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Vaamonde, C. A., Pérez, G. O., Pardo, V.: Dysproteinemias: Multiple Myeloma, Amyloidosis and Renal disorders. In: Schrier, R. W. Gottschalk, C. W.: Diseases of the Kidney. Vth edition, volume III. Boston Little, Brown and comp., 1993, s. 2189-2237.
2. Pahl, M. V., Vaziri, N. D.: Cancer. In: Daugirdas, J. T., Todd, S. I.: Handbook of Dialysis. Boston, Little, Brown and comp., 1994, s. 537-544.
3. Sulková, S., Švára, F.: Dialyzačni léčeni a malignity. In.: Sulková S. et al.: Hemodialýza. Praha, Maxdorf - Jessenius, 2000, s. 460.
4. Knudsen, L. M., Hjorth, M., Hippe, E.: Renal failure and multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur. J. Haematol., 2000, 65, s. 175-181.
5. Klener, P.: Amyloidóza. In: Klener P. et al.: Vnitřni lékarství. Praha, Galén, 1999, s. 385.
6. Baeksgaard, L., Sorensen, J. B.: Acute tumor lysis syndrome in solid tumors - a case report and review of the literature. Cancer Chemother. Pharmacol., 2003, 51, s. 187-192.
7. Viron, B.: Le point sur ... uremie et cancer. Néphrologie, 2002, 23, s. 231-236
8. Laboudi, A., Makdassi, R., Choukroun, G., Fournier, A.: Acute renal failure secondary to interferon. Néphrologic, 2003, 24, s. 1871-1885.
9. Watanabe, M., Aoki, Y., Tomita, M. et al.: Paclitaxel and carboplatin combination chemotherapy in a hemodialysis patient with advenced ovarian cancer. Gynecol. Oncol., 2002, 84, s. 335-338.
10. Maisonneuve, P., Agodoa, L., Gellert, R. et al.: Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet, 1999, 354, s. 90-91.
11. Stewart, J. H., Buccianti, G., Agodoa, L. et al.: Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from United States, Europe, and Australia and New Zealand. J. Am. Soc. Nephrol., 2003, 14, s. 197-207.
12. Ou, J. H., Pan, C. C., Lin, J. S. et al.: Transitional cell carcinoma in dialysis patients. Eur. Urol., 2000, 37, s. 90-94.
13. Teschner, M., Garte, C., Rueckle-Lanz, H. et. Al.: Inzidenz und Spektrum maligner Erkrankungen bei Dialysepatienten in Nordbayern. Dtsch. Med. Wochensch., 2002, 127, s. 2497-2502.
14. Mason, R. G., Donaldson, D.: Chinese herbal nephropathy and urothelial malignancy. J. R. Soc. Health, 2002, 122, s. 266-267.
15. Li, M. K., Choy, D. K., Yip, S. K.: Renal cell carcinoma in patients with chronic renal failure. Ann. Acad. Med. Singapore, 1999, 28, s. 512-515.
16. Palestini, M., Lucandri, G., Sterpeti, A. et al.: Cancer surveillance in patients receiving long-term hemodialysis. Anticancer Res., 2002, 22, s. 1305-1310.
17. Cengiz, K.: Increased incidence of neoplasia in chronic renal failure [20-year experience]. Int. Urol., 2002, 33, s. 121-126.
18. Sumura, M., Yokogi, H., Beppu, M., Honda, H.: Diagnostic value of serum prostate-specific antigen in hemodialysis patients. Int. J. Urol., 2003, 10. s. 247-250.
19. Fujimoto, K., Anal, S., Okajima, E. et al.: Chromophobe cell renal carcinoma with acquired cystic disease of the kidney in a long-term hemodialysis patient. Int. J. Urol., 2003, 10, 99-102.
20. Jaywardene, S., Owen, W. J., Goldsmith, D. J.: Parathyroid carcinoma in a dialysis patient. Am. J. Kidney, 2000, 36, s. 26.
21. Zivaljevic, V., Krgovic, K., Tatic, S, et al.: Parathyroid cancer in a hemodialysis patient: a case report. Tumori, 2002, 88, s. 430-432.
22. Herr, H., Kim, J. U., Kang, G. H. et al.: Kaposi's sarcoma occurring during short-term dialysis: report of two cases. J. Korean Med. Sci., 2001, 16, s. 130-134.
23. Malachi, T., Zevin, D., Gafter, M. et al.: DNA repair and recovery of RNA synthesis in uremic patients. Kidney Int., 1993, 44, s. 385-389.
24. Nagy, A., Wilhelm, M., Kovacs, G.: Mutations of mtDNA in renal cell tumours arising in end-stage renal disease. J. Pathol., 2003, 199, s. 237-242.
25. Křížek, M.: Některé stopové prvky a jejich vliv na kvalitu života u nemocných s chronickou renálni insuficiencí. Doktorská dizertační práce, LF UK Plzeň, 1998, s. 2-106.
26. Kallistratos, G., Evangelou, A., Seferiadis, K. et al.: Selenium in hemodialysis: Serum selenium levels in healthy persons, non-cancer and cancer patients with chronic renal failure. Nephron, 1985, 41, s. 217-222.
27. Denton, M. D., Magee, C. C., Ovuworie, C. et al.: Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int., 2002, 61, s. 2201-2209.
28. Friedman, E. A., Lundin, A. P.: Acquired Cystic Disease of the Kidney. In: Schrier, R. W., Gottschalk, C. W.: Diseases of the Kidney, Vth edition, vol. III. Boston, Little, Brown and comp., 1993, s. 3088.
29. Merta, M.: Vrozená onemocněni ledvin. In: Schück, O., Tesař, V., Teplan, V. et al.: Klinická nefrologie. Praha, Medprint, 1995, s. 107-120.
30. Bargman, J. M.: Neoplasia in dialysis patients: pathophysiology, epidemiology, and screening. Adv. Perit. Dial., 2000, 16, s. 93-96.
31. Djavan, B., Shariat, S., Ghawidel, K. et al.: Impact of chronic dialysis on serum PSA , free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis? Urology, 1999, 53, s. 1169-1174.
32. Bruun, L., Bjork, T., Lilja, H. et al.: Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment. Nephrol. Dial. Transplant, 2003, 18, s. 598-603.
33. Pontoriero, G., Locatelli, F., Ritz, E.: Calcium phosphate and magnesium balance in patients with acute illness. In: Ronco, C., Bellomo, R.: Critical Care Nephrology. Kluwer Academic Publishers, Dordrecht, 1998, s. 211-216.
34. Davidson, T. G.: Conventional treatment of hypercalcemia of malignancy. Am. J. Health Syst. Pharm., 2001 (Suppl. 3), s. 8-15.
35. Mohamed, F., Marchettini, P., Stuart, O. A. et al: A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery. Eur. J. Surg. Oncol., 2003, 29, s. 261-265.
36. Kim, J. Y., Bae, H. S.: A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer, 2001, 4, s. 27-33.
37. McArdle, C. S., Kerr, D. J., O'Gorman, P. et al.: Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma. Br. J. Cancer, 1994, 70, s. 762-766.
38. Young, A., Gilbert, J., Herman, M. et al.: Intraperitoneal chemotherapy: a prolonged infusion of 5-fluorouracil using a novel carrier solution. Br. J. Nurs., 1996, 5, s. 539-543.
39. Mailloux, L. U., Bellucci, A. G., Napolitano, B.: Death by withdrawal from dialysis: 20 years clinical experience. J. Am. Soc. Nephrol., 1993, 3, s. 1631.
40. Eibach, U., Schaefer, K.: Support after discontinuation of dialysis - medical and ethical considerations. Nephrol. Dial. Transplant 1998, 13, s. 1154.